4.7 Article

Predictors of persistent inflammation in familial Mediterranean fever and association with damage

Journal

RHEUMATOLOGY
Volume 60, Issue 1, Pages 333-339

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keaa378

Keywords

familial Mediterranean fever; persistent inflammation; chronic inflammation; subclinical inflammation; autoinflammatory diseases; Autoinflammatory Disease Damage Index; ADDI

Categories

Funding

  1. Hacettepe Rheumatology Association [HRD2018-001]

Ask authors/readers for more resources

This study identified predictors of persistent inflammation in adult FMF patients for the first time, and found that persistent inflammation is a major cause of insidious damage. Male gender, lower education levels, and the presence of other inflammatory comorbidities were found to be more likely to lead to persistent inflammation.
Objective. Persistent inflammation is an insidious and less studied feature of FMF. We investigated clinical determinants of persistent inflammation and its associations with individual damage items. Methods. This is a cross-sectional analysis of 917 FMF patients, who fulfilled the Tel Hashomer criteria and had at least 6 months' follow-up. Patients were stratified based on whether they had persistent inflammation. We used logistic regression analysis to investigate independent predictors of persistent inflammation and the associated individual damage items. Results. One hundred and forty-two (15%) patients had persistent inflammation. Active FMF (54%) was the most prominent reason for the persistent inflammation. Spondylarthritis (16%), other inflammatory arthritis (8%) and IBD (2%) were other frequent reasons. Male gender, history of exertional leg pain, inflammatory comorbidities, M694V homozygosity, colchicine resistance, lower education levels and musculoskeletal attack dominance were found to be the independent predictors of persistent inflammation. Earlier disease onset led to a tendency towards persistent inflammation. Patients with persistent inflammation were more likely to suffer damage. There is an increased risk of developing proteinuria, amyloidosis and renal insufficiency. Conclusion. We identified, for the first time, the predictors of persistent inflammation in adult FMF patients and related individual damage items of the Autoinflammatory Disease Damage Index. Persistent inflammation is insidious and one of the chief causes of damage; therefore, especially patients with these predictors should be followed up more closely. If detected, underlying inflammatory comorbidities should be assessed meticulously as early detection and proper treatment strategies may favourably impact the natural history of the disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease

Aslihan Avanoglu Guler, Tuba Yuce Inel, Timucin Kasifoglu, Cansu Coskun, Hazan Karadeniz, Derya Yildirim, Reyhan Bilici, Hasan Satis, Hamit Kucuk, Seminur Haznedaroglu, Berna Goker, Mehmet Akif Ozturk, Ismail Sari, Abdurrahman Tufan

Summary: The features of familial Mediterranean fever (FMF) do not have a negative impact on the prognosis of COVID-19. Non-adherence to colchicine treatment is a risk factor for requiring hospitalization for respiratory support. The rate of FMF attacks increases significantly after COVID-19, with some of them being prolonged and destructive.

MODERN RHEUMATOLOGY (2023)

Article Immunology

Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

Berkan Armagan, Ebru Atalar, Serdar Can Guven, Bahar Ozdemir, Hatice Ecem Konak, Pinar Akyuz Dagli, Abdulsamet Erden, Kevser Gok, Yuksel Maras, Ismail Dogan, Orhan Kucuksahin, Sukran Erten, Ahmet Omma

Summary: The study aimed to evaluate the impact of sulfasalazine therapy on COVID-19 outcomes in patients with Axial Spondyloarthritis. The results suggest that sulfasalazine may be associated with more severe COVID-19 in AxSpA patients. Therefore, these patients should be closely followed in the presence of COVID-19, and discontinuation of sulfasalazine should be considered.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2023)

Article Rheumatology

Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

Ozlem Karakas, Abdulsamet Erden, Berkan Armagan, Serdar Can Guven, Ebru Atalar, Bunyamin Polat, Ahmet Omma, Orhan Kucuksahin

Summary: The aim of this study was to evaluate the development of side effects and complications in APS patients after COVID-19 vaccination. The study included 35 APS patients who had received at least 1 dose of either CoronaVac or BNT162b2 vaccines. The most common adverse events reported were myalgia and malaise. No vaccine-related thrombotic events or disease flares were observed. Larger-scale studies are needed for more accurate evaluation of side effects in APS patients after COVID-19 vaccination.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Article Rheumatology

Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone

M. Kiraci, E. Bilgin, E. Duran, B. Farisogullari, E. C. Bolek, G. K. Yardimci, Z. Ozsoy, G. Ayan, G. S. Uzun, T. H. Akbaba, B. Balci-Peynircioglu, O. Karadag, A. Akdogan, S. A. Bilgen, S. Kiraz, A. Ertenli, U. Kalyoncu, L. Kilic

Summary: Comparing the features of patients with familial Mediterranean fever (FMF) accompanying axial spondyloarthritis (axSpA) to patients with each condition alone, it was found that patients with FMF + axSpA had earlier onset of axSpA, more severe hip involvement, and higher prevalence of amyloidosis.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Article Obstetrics & Gynecology

Fertility, early menopause and pregnancy outcomes of patients with Takayasu?s arteritis

Arzu Taghiyeva, Levent Kilic, Murat Cagan, Ertugrul Cagri Bolek, Gozde Kubra Yardimci, Ozgur Ozyuncu, Sule Apras Bilgen, Omer Karadag

Summary: This study aimed to evaluate fertility, early menopause, and pregnancy outcomes of patients with Takayasu's arteritis (TA) before and after diagnosis. The results showed that TA patients had a higher infertility rate compared to the general population in Turkey (12.5% vs 8.6%) and a lower rate of early menopause (16.7% vs 36.1%). Pregnancy following a TA diagnosis had more maternal complications, and fetal complications were common both before and after diagnosis. Chronic inflammation may contribute to increased infertility and fetal complications.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2023)

Review Immunology

Tofacitinib experience in patients with enteropathic arthritis

Pinar Akyuez Dagli, Abdulsamet Erden, Serdar Can Gueven, Berkan Armagan, oeykue Tayfur Yuerekli, Yasemin oezderin oezin, Ahmet Omma, Orhan Kuecueksahin

Summary: This study evaluated the effectiveness of tofacitinib in the treatment of enteropathic arthritis. The results showed that after tofacitinib treatment, clinical and laboratory symptoms of both inflammatory bowel disease and arthritis improved in three patients.

IMMUNOTHERAPY (2023)

Article Immunology

Ustekinumab in enteropathic arthritis

Bahar Ozdemir Ulusoy, Abdulsamet Erden, Serdar Can Guven, Berkan Armagan, Oyku Tayfur Yurekli, Yasemin Ozderin Ozin, Ahmet Omma, Orhan Kucuksahin

Summary: Treatments targeting the IL-23 pathway have shown high efficacy in psoriasis, psoriatic arthritis, and inflammatory bowel diseases. This study investigated the effectiveness of ustekinumab, a biological agent blocking the IL-12/23 pathway, in patients with enteropathic arthritis. The results showed that ustekinumab effectively achieved clinical remission in inflammatory bowel disease and enteropathic arthritis, as well as regression of other extraintestinal findings.

IMMUNOTHERAPY (2023)

Article Rheumatology

COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab

Berkan Armagan, Hatice Ecem Konak, Bahar Ozdemir, Hakan Apaydin, Ebru Atalar, Pinar Akyuz Dagli, Serdar Can Guven, Abdulsamet Erden, Orhan Kucuksahin, Ahmet Omma, Sukran Erten

Summary: This study evaluated the frequency, risk factors, and re-infection rates of COVID-19 in patients with autoimmune rheumatic diseases receiving rituximab. The results showed that hypogammaglobulinemia was a significant risk factor for COVID-19 development, and advanced age was associated with more severe disease. Additionally, a high rate of COVID-19 re-infection was observed.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Article Medical Laboratory Technology

Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis

Mehmet Kayaalp, Abdulsamet Erden, Hakan Apaydin, Serdar Can Gueven, Berkan Armagan, Merve Caglayan Kayaalp, Esma Andac Uzdogan, Seymanur Ala Enli, Ahmet Omma, Orhan Kucuksahin

Summary: The study aimed to evaluate the levels of Sema3A in patients with systemic sclerosis (SSc), particularly in major vascular involvements like digital ulcer (DU), scleroderma renal crisis (SRC), pulmonary arterial hypertension (PAH), and to compare Sema3A level with SSc disease activity. The study suggests that Sema3A may play a significant role in the pathogenesis of vasculopathy and can be used as a biomarker in SSc patients with vascular complications such as DU and PAH.

LABORATORY MEDICINE (2023)

Article Medicine, General & Internal

The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease

Onur Keskin, Bayram Farisogullari, Gozde Kubra Yardimci, Burcu Gurbuz, Melike Kole, Erkan Parlak, Omer Karadag, Taylan Kav, Umut Kalyoncu

Summary: This study aimed to determine the effectiveness of adding a simple questionnaire related to the musculoskeletal system to routine outpatient examination to detect undiagnosed axial and peripheral arthropathy in patients with inflammatory bowel disease (IBD). The study found that the DETAIL questionnaire is an effective tool for identifying missed cases of enteropathic arthritis in patients with IBD.

FRONTIERS IN MEDICINE (2023)

Article Rheumatology

IgG4-related pachymeningitis-Long term follow up and outcome of six patients

Gozde Kubra Yardimci, Doruk Arslan, Berrin Babaoglu, Ertugrul Cagri Bolek, Levent Kilic, Arzu Saglam, Asli Tuncer, Figen Soylemezoglu, Rahsan Gocmen, Kader K. Oguz, Ersin Tan, Omer Karadag

Summary: In this study, the HUVAC database was used to evaluate cases of pachymeningitis in patients with IgG4-related disease. It was found that most of these patients had normal serum IgG4 levels, therefore not useful for diagnosis. Typical radiology and tentorial thickening should raise suspicion of IgG4-related disease and prompt early biopsy. With steroids+ rituximab treatment, there was no long-term relapse related to meningeal involvement.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Article Geriatrics & Gerontology

Sleep quality and its associations with disease activity and quality of life in older patients with rheumatoid arthritis

O. Deniz, C. Cavusoglu, H. Satis, R. B. Salman, O. Varan, N. Atas, S. Coteli, R. T. Dogrul, H. Babaoglu, A. Oncul, H. D. Varan, M. C. Kizilarslanoglu, A. Tufan, B. Goker

Summary: This study aimed to compare sleep quality and its associations with disease activity and quality of life between older patients with rheumatoid arthritis and age- and gender-matched controls. The findings showed that older RA patients had poor sleep quality and sleep quality is strongly associated with disease activity and quality of life. In the geriatric population with rheumatologic diseases such as rheumatoid arthritis, sleep quality should be kept in mind and evaluated in routine management.

EUROPEAN GERIATRIC MEDICINE (2023)

Article Rheumatology

Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

Gullu Sandal Uzun, Arzu Taghiyeva, Ibrahim Y. Cakir, Kenan Moral, Gozde Kubra Yardimci, Ertugrul C. Bolek, Bayram Farisogullari, Emine Duran, Gizem Ayan, Zehra Ozsoy, Mustafa Ekici, Erdinc Unaldi, Serife A. Germe, Busra Firlatan, Gozde S. Kart-Bayram, Emre Bilgin, Levent Kilic, Omer Karadag, Ali Akdogan, Sule A. Bilgen, Sedat Kiraz, Ali Ihsan Ertenli, Umut Kalyoncu

Summary: The choice of b/ts-DMARDs, comorbidities, and disease activity control are important factors in the development of CKD in RA patients. The mortality rate did not significantly differ between CKD and non-CKD patients, but both groups experienced increased overall mortality after the COVID-19 pandemic.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Article Rehabilitation

Adaptation and psychometric testing of the Turkish evaluation of daily activity questionnaire in people with rheumatoid arthritis

Gonca Bumin, Alison Hammond, Remziye Akarsu, Yeliz Prior, Buesra Kaplan, Fatma Temizkan, Ozgun Belen, Yusuf Celik, Gozde Kubra Yardimci, Umut Kalyoncu

Summary: The EDAQ was translated into Turkish and tested for validity and reliability in people with RA in Turkey. The Turkish version showed good internal consistency, concurrent validity, and test-retest reliability, making it a reliable tool for assessing daily activity ability in Turkish speakers with RA.

DISABILITY AND REHABILITATION (2023)

No Data Available